FASLG and neoplasm: Additionally, evidence supports the involvement of Fas/Fas Ligand (FasL) interplay in immune evasion [77], with neoplasms showing resistance to Fas-mediated cytotoxicity and FasL expression potentially resulting in immune effector cells apoptosis [76,78].